Researchers are heralding a breakthrough in the treatment of Alzheimer’s: a drug that is the first to slow the destruction of the brain. But it only works in the early stages of Alzheimer’s and many people aren’t diagnosed until the disease has already advanced. Marco Werman speaks with an Alzheimer’s researcher to find out what is so revolutionary about the new drug lecanemab and how it can be made available to those who need it.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!